Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, when the NHS Commissioning Board Special Health Authority first issued a public consultation on funding for Duodopa; what the outcome of that consultation was; and if he will make a statement.

NHS England has advised that it has not conducted a formal consultation process yet but has engaged with stakeholders during the process of developing its draft commissioning policy on the treatment of advanced Parkinson’s disease with Duodopa (co-careldopa) that is awaiting prioritisation later this year.